Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis method offers high enantioselectivity and significant cost reduction for chiral catalyst manufacturing supply chains globally ensuring reliable pharmaceutical intermediates
Novel Pd-catalyzed carbonylation method offers high yields and broad substrate scope for cost-effective API intermediate manufacturing.
Novel one-pot synthesis improves yield and purity for bazedoxifene intermediate. Reduces cost and simplifies supply chain for pharmaceutical partners globally.
Patent CN116813544B reveals metal-free heating method for quinoline compounds. Offers cost reduction in pharma intermediates manufacturing and enhanced supply chain reliability.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chains.
Patent CN111807938A reveals a mild, transition-metal-free synthesis for chloro-iodo olefins. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel CuCl-catalyzed method for 1,2,4-triazolyl arylamines. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN112812032A reveals a green Rh-catalyzed route to acetamides using dimethyl carbonate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108690007B reveals a room-temperature ionic liquid method for ortho-cyanation, offering safer pharma intermediate manufacturing and reduced waste.
Patent CN113121462B reveals a safe, metal-free synthesis for 5-trifluoromethyl-1,2,3-triazoles, offering cost reduction and scalability for pharma intermediates.
Novel Mo/Cu co-catalyzed method for 3-CF3-1,2,4-triazoles. High yield, mild conditions, scalable API intermediate production for global supply chains.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offering cost-effective scale-up and high purity for global API manufacturers.
Patent CN112441981B details a novel one-step synthesis for imidazoles, offering high regioselectivity and supply chain efficiency for pharma intermediates.
Patent CN101792427A details a mild, high-yield route to polysubstituted furans using Au/Pd catalysis, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Novel patent CN117164544A details efficient pyrone synthesis using nitroarenes. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing partners.
Patent CN117126077B reveals a green visible-light iron catalyzed route for 4-arylbutyronitrile. Achieve 100% atom economy and cost reduction in fine chemical manufacturing.
Patent CN106366054B details non-metal catalytic coupling for ketone synthesis. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112125856A reveals a safe palladium-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction and supply chain reliability for API manufacturing.
Patent CN113105402A details a metal-free iodine-catalyzed route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN110283078A reveals a green catalytic route for 1,4-diene compounds. This method offers high purity and scalable manufacturing for pharmaceutical intermediates.